Biodesix/BDSX

$1.58

-1.94%
-
1D1W1MYTD1YMAX

About Biodesix

Biodesix, Inc. (Biodesix) is a data-driven diagnostic solutions company. Biodesix is focused on using technologies with its artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs in lung disease. Biodesix is providing diagnostic testing services associated with blood-based lung tests; coronavirus disease tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development, and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Its blood-based lung cancer tests include Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. Biodesix also offers SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralizing Antibody testing.

Ticker

BDSX

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Scott Hutton

Employees

245

Headquarters

Boulder, United States

Biodesix Metrics

BasicAdvanced
$139.33M
Market cap
-
P/E ratio
-$0.90
EPS
1.13
Beta
-
Dividend rate

What the Analysts think about Biodesix

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 2 analysts.
74.05% upside
High $3.50
Low $2.00
$1.58
Current price
$2.75
Average price target

Biodesix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-81.34% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$13.4M
13.56%
Net income
$-10.9M
-18.05%
Profit margin
-81.34%
-27.83%

Biodesix Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.09%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.24
-$0.17
-$0.14
-$0.10
-
Expected
-$0.24
-$0.21
-$0.15
-$0.11
-$0.14
Surprise
1.41%
-17.74%
-6.67%
-9.09%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Biodesix stock

Buy or sell Biodesix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing